增强面部或面部疼痛缓解:α-phellandrene复合与基烯-β-cyclodextrin缓解面部或面部痛感在动物
Brennda Gonzaga Machado1, Fabíolla Rocha Santos Passos1, Ângelo Roberto Antoniolli1
1Department of Physiology, Federal University of Sergipe (UFS), São Cristóvão, SE, Brazil.
Naunyn-Schmiedeberg's archives of pharmacology
|November 4, 2024
概括
一项新的研究表明,阿尔法-费兰德 (PHE) 与基-β-环氧德 (PHE-HPβCD) 复合有效地减少了面部或面部疼痛. 这种有前途的治疗可以缓解疼痛和炎症,为新的口腔面部疼痛疗法提供了潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
- 自然产品 自然产品
背景情况:
- 面部或口腔疼痛影响10-15%的成年人,这给治疗带来了重大挑战.
- 阿尔法-费兰德烯 (PHE) 是一种单烯,在缓解疼痛方面显示出潜在的治疗益处.
- 开发有效的输送系统对于提高PHE的治疗疗效至关重要.
研究的目的:
- 开发和表征一个包含的复杂的α-phellandrene (PHE) 与xypropyl-β-cyclodextrin (PHE-HPβCD).
- 为了评估PHE-HPβCD在临床前的口腔面部疼痛模型中的疗效.
- 调查PHE-HPβCD对 orofacial疼痛中的炎症媒介的影响.
主要方法:
- 通过物理混合制备的PHE-HPβCD纳入复合物.
- 使用差分扫描热量计 (DSC) 和高性能液体染色学 (HPLC) 进行表征.
- 评估小鼠的口面疼痛模型 (甲素,甲,谷氨酸,高血压盐水) 并测量TNF-α和IL-1β水平.
主要成果:
- 该PHE-HPβCD复合体实现了70.45%的封装效率.
- 无论是PHE还是PHE-HPβCD,都在甲素诱导的口腔面部疼痛中表现出显著的抗受体效应.
- PHE-HPβCD显著降低了促炎性细胞因子TNF-α和IL-1β,并改善了角膜 nociception.
结论:
- PHE,特别是在PHE-HPβCD复合体中,通过调节疼痛通路和减少炎症,有效地缓解口腔疼痛.
- 该复合物显示出治疗各种口腔面部疼痛疾病的潜力,包括涉及TRPA1/TRPV1受体和谷氨酸酸的疾病.
- PHE-HPβCD代表了一种有前途的治疗策略来控制面部疼痛,需要在慢性疼痛模型中进一步调查.
相关概念视频
Analgesia and Pain Management
525
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
525
Opioid Analgesics: Synthetic and Semisynthetic Opioids
232
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
232


